These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 25398823)

  • 21. The Prevention of Post-Partum Relapses with Progestin and Estradiol in Multiple Sclerosis (POPART'MUS) trial: rationale, objectives and state of advancement.
    Vukusic S; Ionescu I; El-Etr M; Schumacher M; Baulieu EE; Cornu C; Confavreux C;
    J Neurol Sci; 2009 Nov; 286(1-2):114-8. PubMed ID: 19758607
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Ceruloplasmin activity in the blood during progressive diseases of the central nervous system].
    Mzhel'skaia TI; Zavalishin IA; Ivanova-Smolenskaia IA; Larskiĭ EG; Basevich VV; Markova ED; Niiazbekova AS
    Lab Delo; 1989; (11):12-6. PubMed ID: 2481091
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biological markers in cerebrospinal fluid for axonal impairment in multiple sclerosis: acetylcholinesterase activity cannot be considered a useful biomarker.
    Antonelli T; Tomasini MC; Castellazzi M; Sola P; Tamborino C; Ferraro D; Ferraro L; Granieri E
    Neurol Sci; 2013 May; 34(5):769-71. PubMed ID: 23247598
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased autotaxin activity in multiple sclerosis.
    Zahednasab H; Balood M; Harirchian MH; Mesbah-Namin SA; Rahimian N; Siroos B
    J Neuroimmunol; 2014 Aug; 273(1-2):120-3. PubMed ID: 24984830
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oxidative stress in serum and peripheral blood leukocytes in patients with different disease courses of multiple sclerosis.
    Koch M; Ramsaransing GS; Arutjunyan AV; Stepanov M; Teelken A; Heersema DJ; De Keyser J
    J Neurol; 2006 Apr; 253(4):483-7. PubMed ID: 16283096
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cerebrospinal fluid anti-whole myelin antibodies are not correlated to magnetic resonance imaging activity in multiple sclerosis.
    Tewarie P; Teunissen CE; Dijkstra CD; Heijnen DA; Vogt M; Balk L; Vrenken H; Polman CH; Killestein J
    J Neuroimmunol; 2012 Oct; 251(1-2):103-6. PubMed ID: 22858371
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum prolactin level in patients with multiple sclerosis: a case control study.
    Harirchian MH; Sahraian MA; Shirani A
    Med Sci Monit; 2006 Apr; 12(4):CR177-80. PubMed ID: 16572053
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determinants of disability in multiple sclerosis at various disease stages: a multiparametric magnetic resonance study.
    Pulizzi A; Rovaris M; Judica E; Sormani MP; Martinelli V; Comi G; Filippi M
    Arch Neurol; 2007 Aug; 64(8):1163-8. PubMed ID: 17698707
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coenzyme Q10 supplementation reduces oxidative stress and increases antioxidant enzyme activity in patients with relapsing-remitting multiple sclerosis.
    Sanoobar M; Eghtesadi S; Azimi A; Khalili M; Jazayeri S; Reza Gohari M
    Int J Neurosci; 2013 Nov; 123(11):776-82. PubMed ID: 23659338
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The ferroxidase activity of caeruloplasmin is reduced in haemodialysis patients.
    Roxborough HE; Mercer C; McMaster D; Maxwell AP; Young IS
    Nephron; 2000 Mar; 84(3):211-7. PubMed ID: 10720890
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low serum ferroxidase I activity is associated with mortality in heart failure and related to both peroxynitrite-induced cysteine oxidation and tyrosine nitration of ceruloplasmin.
    Cabassi A; Binno SM; Tedeschi S; Ruzicka V; Dancelli S; Rocco R; Vicini V; Coghi P; Regolisti G; Montanari A; Fiaccadori E; Govoni P; Piepoli M; de Champlain J
    Circ Res; 2014 May; 114(11):1723-32. PubMed ID: 24687133
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Copper and ceruloplasmin dyshomeostasis in serum and cerebrospinal fluid of multiple sclerosis subjects.
    De Riccardis L; Buccolieri A; Muci M; Pitotti E; De Robertis F; Trianni G; Manno D; Maffia M
    Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt A):1828-1838. PubMed ID: 29524632
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oxidative Stress Related to Iron Metabolism in Relapsing Remitting Multiple Sclerosis Patients With Low Disability.
    Siotto M; Filippi MM; Simonelli I; Landi D; Ghazaryan A; Vollaro S; Ventriglia M; Pasqualetti P; Rongioletti MCA; Squitti R; Vernieri F
    Front Neurosci; 2019; 13():86. PubMed ID: 30804745
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunoadsorption patients with multiple sclerosis: an open-label pilot study.
    Moldenhauer A; Haas J; Wäscher C; Derfuss T; Hoffmann KT; Kiesewetter H; Salama A
    Eur J Clin Invest; 2005 Aug; 35(8):523-30. PubMed ID: 16101673
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuronal injury in chronic CNS inflammation.
    Zindler E; Zipp F
    Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):551-62. PubMed ID: 21619866
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The diagnosis of multiple sclerosis and the various related demyelinating syndromes: a critical review.
    Karussis D
    J Autoimmun; 2014; 48-49():134-42. PubMed ID: 24524923
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiple sclerosis update.
    Markowitz CE
    Am J Manag Care; 2013 Nov; 19(16 Suppl):s294-300. PubMed ID: 24494618
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alteration of prolyl oligopeptidase and activated α-2-macroglobulin in multiple sclerosis subtypes and in the clinically isolated syndrome.
    Tenorio-Laranga J; Peltonen I; Keskitalo S; Duran-Torres G; Natarajan R; Männistö PT; Nurmi A; Vartiainen N; Airas L; Elovaara I; García-Horsman JA
    Biochem Pharmacol; 2013 Jun; 85(12):1783-94. PubMed ID: 23643808
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Arterial compliance in multiple sclerosis: a pilot study.
    Fjeldstad C; Frederiksen C; Fjeldstad AS; Bemben M; Pardo G
    Angiology; 2010; 61(1):31-6. PubMed ID: 19497928
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of smoking on ceruloplasmin and its ferroxidase activity in pregnant women.
    Dalamaga AL; Agroyannis B; Vitoratos N; Frangos-Plemenos M; Patsouras K; Kostoglou-Papalamprou M; Zourlas PA
    Gynecol Obstet Invest; 1996; 42(1):13-5. PubMed ID: 8840170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.